omega-n-methylarginine has been researched along with noc 9 in 2 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (noc 9) | Trials (noc 9) | Recent Studies (post-2010) (noc 9) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 25 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dirsch, VM; Leikert, JF; Müller, C; Räthel, TR; Vollmar, AM | 1 |
| Frenneaux, MP; James, PE; Lang, D; Milsom, AB; Tufnell-Barret, T | 1 |
2 other study(ies) available for omega-n-methylarginine and noc 9
| Article | Year |
|---|---|
Reliable in vitro measurement of nitric oxide released from endothelial cells using low concentrations of the fluorescent probe 4,5-diaminofluorescein.
Topics: Cell Line; Endothelium, Vascular; Enzyme Inhibitors; Fluorescein; Fluorescent Dyes; Humans; Molecular Structure; Nitric Oxide; omega-N-Methylarginine; Spectrometry, Fluorescence; Tetradecanoylphorbol Acetate; Triazenes | 2001 |
Vasorelaxation by red blood cells and impairment in diabetes: reduced nitric oxide and oxygen delivery by glycated hemoglobin.
Topics: Animals; Aorta, Thoracic; Cell Hypoxia; Diabetes Mellitus; Endothelium, Vascular; Erythrocytes; Glycated Hemoglobin; Glycosylation; Hemoglobins; Male; Microcirculation; Nitric Oxide; omega-N-Methylarginine; Oxygen; Phenylephrine; Rabbits; Triazenes; Vasoconstrictor Agents; Vasodilation | 2004 |